Prospective Parallel Randomized, Double-Blind, Double-Dummy Controlled Clinical Trial Comparing Clomiphene Citrate and Metformin as the First-Line Treatment for Ovulation Induction in Nonobese Anovulatory Women with Polycystic Ovary Syndrome
Open Access
- 1 July 2005
- journal article
- clinical trial
- Published by The Endocrine Society in The Journal of Clinical Endocrinology & Metabolism
- Vol. 90 (7) , 4068-4074
Abstract
Context: Although metformin has been shown to be effective in the treatment of anovulation in women with polycystic ovary syndrome (PCOS), clomiphene citrate (CC) is still considered to be the first-line drug to induce ovulation in these patients. Objective: The goal of this study was to compare the effectiveness of metformin and CC administration as a first-line treatment in anovulatory women with PCOS. Design: We describe a prospective parallel randomized, double-blind, double-dummy controlled clinical trial. Setting: The study was conducted at the University “Magna Graecia” of Catanzaro, Catanzaro, Italy. Patients: One hundred nonobese primary infertile anovulatory women with PCOS participated. Interventions: We administered metformin cloridrate (850 mg twice daily) plus placebo (group A) or placebo plus CC (150 mg for 5 d from the third day of a progesterone withdrawal bleeding) (group B) for 6 months each. Mean outcome measures: The main outcome measures were ovulation, pregnancy, abortion, and live-birth rates. Results: The subjects of groups A (n = 45) and B (n = 47) were studied for a total of 205 and 221 cycles, respectively. The ovulation rate was not statistically different between either treatment group (62.9 vs. 67.0%, P = 0.38), whereas the pregnancy rate was significantly higher in group A than group B (15.1 vs. 7.2%, P = 0.009). The difference found between groups A and B regarding the abortion rate was significant (9.7 vs. 37.5%, P = 0.045), whereas a positive trend was observed for the live-birth rate (83.9 vs. 56.3%, P = 0.07). The cumulative pregnancy rate was significantly higher in group A than group B (68.9 vs. 34.0%, P < 0.001). Conclusions: Six-month metformin administration is significantly more effective than six-cycle CC treatment in improving fertility in anovulatory nonobese PCOS women.Keywords
This publication has 35 references indexed in Scilit:
- Is ovulation induction still a therapeutic problem in patients with polycystic ovary syndrome?Journal of Endocrinological Investigation, 2004
- Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndromeFertility and Sterility, 2004
- AnovulationBMJ, 2003
- Descriptive review of the evidence for the use of metformin in polycystic ovary syndromeThe Lancet, 2003
- Modern use of clomiphene citrate in induction of ovulationHuman Reproduction Update, 1997
- Polycystic Ovary SyndromeNew England Journal of Medicine, 1995
- Clomiphene citrate: mechanism(s) and site(s) of action—a hypothesis revisitedFertility and Sterility, 1984
- Induction of Ovulation with MRL/41JAMA, 1961
- Chemical Induction of OvulationFertility and Sterility, 1961
- Gonadotrophin Inhibiting and Anti-Fecundity Effects of Chloramiphene.Experimental Biology and Medicine, 1960